Benzinga's Top #PreMarket Gainers
June 18, 2014 at 08:05 AM EDT
Insmed (NASDAQ: INSM) soared 29.48% to $16.14 in the pre-market trading on the FDA Breakthrough Therapy Designation for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.